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ABSTRACT: During the early stages of β amyloid (Ab) peptide aggregation, toxic
oligomers form which have been recognized as a likely cause of Alzheimer’s disease. In this
work, we use fully atomistic molecular dynamics simulation to study the amorphous
aggregation of the peptide as well as model β-sheet protoﬁbril structures. In particular, we
study the rotamer states of the single ﬂuorescent tyrosine (Tyr) residue present in each Ab.
We ﬁnd that the occupation of the four previously identiﬁed rotamers is diﬀerent for
monomeric and amorphous aggregates because of the diﬀering environments of the Tyr
side-chains. Surprisingly, we also identify two new rotamers that uniquely appear for the β-
sheet structures, so that together the rotamers provide distinct signatures for the diﬀerent
stages of aggregation and ﬁbrillation. We propose that these rotamers could be identiﬁed in
ﬂuorescence spectroscopy, with each rotamer having a distinct ﬂuorescence lifetime
because of its diﬀerent exposures to the solvent. The identiﬁcation of the two new
rotamers therefore provides a new means to probe amyloid formation kinetics and to
monitor the eﬀect of additives including prospective drugs.
■ INTRODUCTION
Because of advances in the medical ﬁeld, the average life
expectancy of the population of many countries is increasing
every year and, consequently, the global population aﬀected by
amyloid-related diseases has also been increasing.1,2 Amyloid-
related diseases occur when certain proteins, naturally found in
the body, stop functioning correctly and begin to rapidly
aggregate forming large β-sheet plaques. During the
aggregation phase, extreme cellular degeneration occurs,
most likely at the oligomer stage of aggregation,3 leading to
diseases such as Alzheimer’s, type-2 diabetes and Lewy body
myositis. The malfunctioning proteins appear to diﬀer for each
disease.1,4,5 These proteins all form β-sheet ﬁbrils; in the case
of Alzheimer’s, the ﬁbrils are deposited in the brain and in
type-2 diabetes, they are deposited in the pancreas.4 This paper
focuses on the β amyloid (Ab) peptide that is associated with
Alzheimer’s disease.
The natural function of Ab peptide is not fully understood,
and there is no apparent change to (or loss of) physiological
functions in animals that have the Ab peptide missing.6−8
However, some potential explanations for the role of Ab in
vivo have been proposed by various researchers; Bogoyevitch
et al.9 showed that it could be a requirement for kinase enzyme
activation, and this has been supplemented by further work in
the area.10 It may also be related to oxidative stress
protection,11,12 cholesterol transport regulation,13,14 the
prevention of microbial activity,15 or play a role as a
transcription factor.16,17 Regardless, the Ab peptides eventually
stop functioning correctly and begin to aggregate, creating the
toxic oligomer stage that contributes to the disease develop-
ment.
Despite the signiﬁcant interest in the research community,
there are many aspects of the aggregation process that require
better understanding to inform strategies to prevent or modify
the aggregation. Experimentally, in vitro techniques can be
used to study the aggregation; however, it is diﬃcult to
determine the ﬁbril nucleation events that occur on the
molecular level. This makes obtaining a detailed understanding
of aggregation pathways impossible using one method alone.
Ab is a small protein (or peptide, with 36−43 amino acids)
that contains a single tyrosine (Tyr) residue,18 which allows
ﬂuorescence measurements to be used to monitor Ab
aggregation in vitro. The change in ﬂuorescence decays over
time observed in these experiments is due to the environ-
mental changes of the Tyr residues and so can be used to infer
the temporal progression of the aggregation.19 The literature
shows that starting with dispersed monomeric Ab peptide at
high concentration, there is a clear lag phase where no
aggregate growth occurs, followed by a rapid formation of long
mature ﬁbrils containing a backbone held by hydrogen
bonding in the form of β-sheets. Previous research using
ﬂuorescence spectroscopy also shows that the Tyr side-chain
goes through rapid changes during the initial stages of
aggregation, but very quickly stabilises.20 This is then followed
by the rapid growth phase where ﬂuorescence dye spectros-
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copy reveals the rapid formation of β-sheets.21 Once
aggregation occurs, the lifetimes associated with the Tyr
side-chains also change, reﬂecting the new Tyr environments
(named rotamer states) not found in the monomer form of Ab.
Though the changes to the ﬂuorescence responses can be
measured, understanding how and why these changes occur is
not clear through experimentation alone. The work in this
paper describes fully atomistic molecular dynamic (MD)
simulations, where the primary focus is to observe the eﬀects of
diﬀering local environments on the Tyr residues and their
resultant conformations. In the previous work, we have shown
how MD simulation can help interpret ﬂuorescence anisotropy
experiments monitoring Ab aggregation.22 In this study, we
reveal new rotamer states that seem to be uniquely associated
with ﬁbril structures and absent from monomer or amorphous
aggregates. These new rotamers are expected to have their own
ﬂuorescence lifetimes because each rotamer exposes the
ﬂuorescent side-chains to solvent in a diﬀerent way. Therefore,
our results oﬀer the potential for a new ﬂuorescence
spectroscopy feature that can directly monitor ﬁbril nucleation,
as opposed to amorphous aggregation, without the need for
external labeling with ﬂuorescent dyes. A capability to monitor
the formation pathway of the ﬁbrils (monomers to oligomer to
ﬁbril) in vitro, and potentially also in vivo, would not only
provide new scientiﬁc insight but also help in the search for
inhibitors to prevent aggregation or for incipients to promote
ﬁbril formation from the toxic oligomers.
■ MATERIALS AND METHODS
Fully atomistic MD simulations of Ab1−42 systems were
performed in this work. All simulations were performed
using NAMD 2.823 and the Charmm27 force ﬁeld, with
VMD24 employed to prepare the simulations, visualize the
results, and track the orientation of the tyrosine residues.
Standard Charmm27 protonation states have been used, and
stability tests for single Ab1−42 peptides in a NaCl solution
show no tendency for abnormal folding; additional data are
provided in the Supporting Information. The ﬁrst set of
simulations used monomers and amorphous aggregates, which
were created using an NMR structure of Ab1−42 (1iyt.pdb)
taken from the protein data bank and obtained by Crescenzi et
al.25 These systems were compared to potential protoﬁbril
structures found by Wal̈ti et al. (2nao.pdb),26 using solvent
(water) with both zero and physiologically relevant bulk
iconicity.
The 1iyt.pdb structure was copied as required for the various
aggregation simulations, and the Ab1−42 peptides were
positioned with an adequate distance between them to ensure
they aggregated in a natural manner during the simulations.
Generally, there was at least 12 Å between peptides at the start
of the simulations, except when trying to promote aggregation;
in the small water-box three-peptide system (which despite
this, only formed a dimer), the starting distance between
peptides was 7 Å. These (and the 2nao systems) were then
solvated using a TIP3P water model with adequately sized
rectangular water boxes, ∼90 Å × 94 Å × 87 Å for the system
with excess ions (EI) and ∼72 Å × 99 Å × 87 Å for the system
without EIs (NEI). The EI system is understood as a Ab1−42
system with counterions neutralizing the system and some
additional Na+/Cl− ions to achieve the desired ionic
concentration, whereas the system without EIs (NEIs) is one
with Ab1−42 neutralized only and no extra ions added. We
study two simulations with Na+ and Cl− ions added to mimic
the ionic concentration of blood, ∼0.15 mol/L;27 the ﬁrst is a
nonaggregating three monomer system, and the second is a
hexamer protoﬁbril.
A water minimization stage (1000 steps) 100 ps of water
equilibration was performed on each of these systems. The
Langevin piston control pressure was activated with group-
based pressure control, a piston temperature of 300 K, and
anisotropic cell ﬂuctuations as in previous work.28 A
minimization phase followed (10 000 steps), before a 30 ps
period of heating to 300 K for amorphous systems or 310 K
(body temperature) for the ﬁbril-like systems, both to a
pressure of 1 atm. The ﬁnal thermal equilibration required 270
ps, with a time-step of 1 fs. The production trajectories were
performed with a time-step of 2 fs, at 300 K (or 310 K) in the
NVT ensemble. The trajectory time varies from 50 to 200 ns
depending on the system studied. Although this is a relatively
short simulation time, the early events in the oligomerization
process, which are in focus of this work, are captured. The
SHAKE algorithm and periodic boundary conditions were
employed. van der Waals (vdW) interactions had a cutoﬀ of 12
Å, and PME is used for the electrostatics.
Figure 1. (A) Dihedral angles Cα−Cβ and Cβ−Cγ used in this work,
following ref 28. (B) Dihedral angle quadrants used to identify the
rotamer states. X1 and X2 angle conformations (g+, g−, and t) are
indicated.29 (C) VMD images of the six rotamer states.
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The tyrosine (Tyr) residue within each Ab1−42 peptide was
tracked using VMD to obtain the Tyr rotamer states (preferred
orientations). This follows previous work, which showed that
the Tyr residues rotate along the Cα−Cβ and the Cβ−Cγ
bonds.28 These angles were tracked for each “frame” of the
trajectory (every 20 000 integration steps) by using the
dihedral angles along the sets of atoms C−Cα−Cβ−Cγ and
Cα−Cβ−Cγ−CD1, which we label angles X1 and X2 respectively,
as shown in Figure 1A. In this work, each frame of the analyzed
trajectory depicts a passage of 0.04 ns; this is chosen to avoid
oversampling the THz molecular vibrations.
At each frame, the dihedral angles are plotted to show the
preferred orientations (i.e., rotamer states) of the Tyr residues.
We use the range 0°−360° to denote the angles (as opposed to
−180° to 180°) for clarity of presentation. In these plots, we
are able to distinguish the states by splitting the X1 − X2 plane
into six zones, as illustrated in Figure 1B. The X2 angle is
divided into two equal sections, and X1 into three. This allows
us to quickly and unambiguously identify 6 possible rotamer
states (see below for veriﬁcation that this assignment is
consistent with the full set of results obtained in this study).
The six rotamer states are illustrated in Figure 1C.
It should be noted that the previous work had only shown
the presence of the ﬁrst four rotamer states,28 and the work
presented in this paper revealed that the ﬁfth and sixth rotamer
states become occupied in the protoﬁbril structures (see Figure
1C). This suggests that they would also appear in larger
structures such as amyloid ﬁbrils (see results below). We note
that because of the lack of symmetry along the peptide
backbone and the unique sequence of the peptide, the rotamer
states 5 and 6 are distinct and diﬀerent to the other states.
■ RESULTS
Ab1−42 Amorphous Aggregation.We aim to characterize
the rotamer states, their occupancy, and the transition
pathways between them in various small oligomers. We are
also interested in how the oligomers form, and whether this
inﬂuences the rotamer statistics. Therefore, we undertake a
series of simulations for the following systems:
• Monomers with EIs and without (NEI);
• Dimers in ionic solutions (EI); and
• A tetramer in an ionic solution (EI).
The aggregation simulations allow the oligomers to form in a
natural way, simulating the oligomerization that can occur
experimentally as monomers diﬀuse freely through the
solution.
Monomers in Ionic Solution. Figure 2 shows results of
simulations with three peptides diﬀusing in a small water box
with an ionic concentration of 0.15 mol/L (EI system). The
extent of the water box is illustrated by the ions in Figure 2A,B
(the water is not shown for clarity). The dimensions of Ab1−42
monomers when in a stable folded conformation is ∼25 Å ×
24 Å × 10 Å, and the water box is of size ∼83 Å × 87 Å × 102
Å. Despite the crowded environment, in this simulation, the
monomers do not appear to be interacting with one another.
This suggests that aggregation (i.e., the formation of close
contacts between peptides) does not occur readily and that
perhaps something must initiate it, such as misfolding,30 which
has been observed in other trajectories below.
The proteins begin close together and yet remain
independent with little interaction with one another
throughout the trajectory. The changes to the peptides’
conformations during this trajectory are minimal, as seen in
Figure 2B. The heads (low-index residues at the N-terminus)
and tails (high index at the C-terminus) of the peptides appear
to unravel in a manner similar to that found in the literature,31
and the helix sections32,33 are focused around residues 11−22
and 32−36 in all three peptides. This creates the initial “L”-
shape of the peptides which might eventually lead to the
formation of an antiparallel β-sheet structure (or hairpin
motif).32
Figure 2. Three-monomer system in an ionic solution (EI): at
trajectory time = 0 ns (A) and after 50 ns (B) with peptide A shown
in blue, peptide B shown in red, and peptide C shown in gray. The
vdW spheres of the ions are shown in gray and Tyr residues are shown
in green. In (C), the left-hand graph shows the plots of X1 against X2
and the right-hand graph shows the rotamer states of peptide A’s Tyr
residue at each frame, with transitions indicated by the blue lines.
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The rotamer states are identiﬁed by tracking the two
dihedral angles of the Tyr residues, and results for Tyr A are
shown in Figure 2C. This clearly shows the rotamer states 1, 2,
3, and 4 (see Figure 1B) occupied by the Tyr side-chain
throughout the trajectory. The rotamers 1−4 for Tyr A are
approximately centered around the (X1;X2) angles (in degrees)
of (67;239), (74;81), (166;116), and (168;291), respectively.
We ﬁnd similar rotamers for Tyr B at approximately (66;239),
(72;108), (112;164), (166;277), and (290;170), and for Tyr C
at approximately (69;270), (73;67), (168;117), and
(166;305). A full list of the rotamer centers found in all our
simulations is provided in the Supporting Information.
Because the three monomers are relatively unhindered by
their surroundings and appear to diﬀuse freely, their rotamer
state occupancies are all similar. As long as they are folded into
stable conformations, they appear to show a distinct preference
for states 1 and 2. It can also be noted that there is more
frequent movement between states 3 and 4 than in state 2,
showing that the Tyr does not ﬁnd states 3 and 4 favorable for
long periods of time in the monomeric peptide. Moreover, Tyr
side-chain transitions between the rotamers tend to appear in a
cyclic fashion. Transitions observed are 1 ↔ 2, 2 ↔ 3, 3 ↔ 4,
and 4↔ 1. This is associated with the proximity of the rotamer
states illustrated in Figure 1C.
In order to verify these ﬁndings, we have studied many
monomer systems for both Ab1−42 and some Ab1−40 systems
(see the Supporting Information). In the case of Ab1−42, we
have studied two other systems. The ﬁrst is a three monomer
system with no EIs (NEI), and the second (also NEI) contains
a monomer and a dimer. These provided a comparison to
assess the eﬀect of the screening ions on the Tyr rotamer state
occupation and movements.
The results (shown in the Supporting Information) indicate
that a visibly more stable conformation is found when the
solution ions are present (the EI system). However, we do not
attempt to quantify the conformations because all of the
amorphous structures are prone to ﬂuctuations as we might
expect for small peptides and oligomers. The Tyr side-chains
always have a preference toward occupation of states 1 and 2,
with a relatively lower population of states 3 and 4, regardless
of the presence of the ions. The only exceptions we have
observed in the “monomeric” systems were instances of
occupation of states 3 and 4 only (or in sometimes only one of
these states). However, in these cases, the results can be
explained by the close proximity of the Tyr side-chain to
surrounding residues or to the backbone of another peptide,
preventing free movement between rotamer states, and thus
explaining the discrepancy with truly free monomer behavior.
Ab1−42 Dimers. A 50 ns trajectory containing four
monomers (NEI) that then formed two dimers is illustrated
in Figure 3. The water box containing the peptides is ∼73 Å ×
99 Å × 90 Å, which ensures that no cross-boundary
interactions occur between a peptide’s head and tail because
of the periodicity, because the dimensions of the Ab1−42
monomers (stated previously) are signiﬁcantly smaller than
the total size of the water box.
The initial stages of the trajectory have the four monomers
relatively close in proximity. The misfolding or conformational
changes shown here are more signiﬁcant than those seen in the
previous monomer systems, which could explain why this
system more readily aggregates.26,31 Monomers C and D start
interacting fairly early and form a dimer by around 20 ns,
whereas monomer A moves down, passes through the bottom
of the water-box, wraps around to the top of the water-box
(due to the periodicity), and begins to interact with monomer
B at approximately 37.5 ns. The last 12.5 ns of the trajectory
contains two dimers, which predominantly have alpha helix
structures.32,33 The only caveat is that once peptide B begins to
aggregate, its alpha helix coil becomes signiﬁcantly shorter than
that in the other peptides for brief periods, changes that have
been seen elsewhere.31
Figure 3. Two-dimer system at time = 0, 20, and 50 ns. Peptide A is
shown in blue, peptide B in red, peptide C in gray, and peptide D in
orange. The gray vdW spheres for the atoms illustrate the protein
surfaces and the Tyr residues are shown in green.
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The trends in Figure 4 are repeatedly observed in our Ab
aggregating simulations. Peptides A and B spend most of the
trajectory as monomers, which is reﬂected in their Tyr rotamer
data. They spend the majority of the early stages in states 1 and
2, as has been shown to be the preference for monomers. They
then show substantial occupation of states 3 and 4 from
around frame 800 (32 ns), which is the time they begin
interacting closely to form a stable aggregate soon after (at
37.5 ns). This further suggests that there is an occupational
preference of states 1 and 2 when in the monomer form and
states 3 and 4 when in an amorphous aggregate because of the
more crowded environment.
This pattern is also shown by peptides C and D that
aggregate fairly early in the trajectory; there is a rapid shift
toward states 3 and 4, with some random ﬂuctuations as might
be expected. Tyr C’s preference for state 1 near the end of the
trajectory suggests that it has become constrained by its
surroundings.
Ab1−42 Tetramer. A short 30 ns simulation containing six
monomers (NEI) is shown in Figure 5. It begins to form an
amorphous aggregate early on in the trajectory because of the
relatively small water-box surrounding the peptides (dimen-
sions ∼72 Å × 99 Å × 87 Å), revealing information about the
how the Tyr side-chains are aﬀected by their immediate
environment.
In Figure 5, the monomers are seen to aggregate within a
few nanosecond. This is diﬀerent from previous simulations,
driven by their close proximity which also seems to promote
monomer misfolding.32,34 The antiparallel β-sheets that form
between the head and tail of peptide D (folding over on itself
to do this) and the head of peptide B (the head creates a small
hairpin motif)28 are also visible by the end of the trajectory.
Other than this all peptides share the features of a helical
structure.33
Monomers A and B begin to aggregate together forming a
dimer and monomers C through F begin to form a tetramer
during the ﬁrst 4.8 ns. By 7.2 ns, it appears that all six peptides
are interacting and show signs of beginning to form an
amorphous hexamer. However, at 26.4 ns, peptides D and F
break away from the aggregate as a dimer and peptides A, B, C,
and E remain as a tetramer for the remainder of the trajectory.
We will now focus on the behavior of the Try residues in these
four peptides that make this tetramer.
Despite the short duration of this simulation, we obtain
informative data about the rotamer states at the early stages of
the oligomerization process, as shown in Figure 6. Tyr A is
mostly unaﬀected by its surroundings and shows a distinct
preference to states 1 and 2 similar to the behavior of some
monomers. Tyr B spends much of the trajectory with freedom
to move, but does interact with the aggregate at ∼20 ns, which
is reﬂected in a short-lived occupation of states 3 and 4 at
around 20 ns (frame 500 in Figure 6), which further suggests
that states 3 and 4 are occupied when local interactions aﬀect
(but do not trap) the Tyr side-chain. Tyr C has similar results
with some occupation of states 3 and 4 most likely associated
with closeness of the neighboring residues and surrounding
aggregate. Tyr E shows a preference to states 3 and 4
inﬂuenced by the close interactions of its neighboring residues
and perhaps also the proximity to peptide C.
From this, it is notable that once aggregated, these Tyr
residues have a tendency to prefer states 3 and 4, behavior
observed above for the dimers. However, this phenomenon is
not universally true because of the random nature of the
amorphous aggregation process that determines the immediate
environment of the Tyr residues.
Ab1−42 Protoﬁbril Systems. We now aim to contrast the
rotamer state statistics of the amorphous oligomers to those
observed in a model protoﬁbril structure. Speciﬁcally, we
characterize the rotamer behavior in the following systems:
• Protoﬁbril hexamer without EIs (NEI); and
• Protoﬁbril hexamer with EIs.
Figure 4. Dimer rotamer states. In each panel, the left graph plots the dihedral angle X1 against X2, and the right graph shows how the Tyr residues
move between the rotamer states. (A−D) Peptides A−D, respectively.
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Hexamer without EIs in Solution (NEI). The ﬁnal type of
system discussed in this paper (in comparison with the
monomer and amorphous aggregate systems) is the protoﬁbril
hexamer structure (both EI and NEI systems) shown in Figure
7 which has been created from 2nao.pdb.26 Here, the
individual peptides have unravelled, losing their helical
structure, and have formed strong β-sheet bonds. It has been
proposed that this is the basic building block required in the
formation of ﬁbrils. The peptides in this hexamer have a very
diﬀerent structure to those in the amorphous aggregates
discussed above, and as we will show, this causes changes to
the Tyr rotamer statistics.
In the simulated structure, the hexamer has dimensions ∼84
Å × 52 Å × 14 Å and the overall water-box size is large enough
(∼90 Å × 94 Å × 87 Å) to ensure that there is no aggregation
artiﬁcially induced by the periodic boundaries, although there
could be some long-range interactions aﬀecting the Tyr side-
chain movements. A larger water-box would be beneﬁcial, but
the increased size of the calculation would increase the
computational costs.
This trajectory starts with the protoﬁbril in a conﬁguration
found from NMR experimentation (see Figure 7A) and
therefore should be stable. However, as the NEI trajectory
begins, the backbone regions around the Tyr side-chains of
peptides D, E, and F spread apart, whereas A, B, and C remain
rigid and relatively close together. After 20 ns, there are some
signiﬁcant conformational changes visible near the head of the
peptides in the stack containing peptides A−C. In contrast, the
changes seen for peptides D−F are less signiﬁcant. By 40 ns,
the structure has moved further from the original conforma-
tional shape, with a lot of the β-sheet sections beginning to
shift, but it can still be identiﬁed as a hexamer protoﬁbril. After
60 ns, the stacked portion containing peptides A−C is further
misshapen but its β-sheet structuring has mostly remained
intact and the stack containing D−F remains relatively
structured throughout. After 100 ns, the aggregate maintains
the structure it has at that point for approximately 30 ns and
then the middle sections of the peptides’ backbones spread out
again.
As apparent in Figure 7B, by the end of the NEI simulation,
the backbones of the peptides are not aggregated as rigidly as
might be expected and they are further apart in the middle of
the structure than they were at the start of the trajectory. It
should also be noted that Tyr E (in the middle layer of one
side of the hexamer stack) has signiﬁcantly more room to move
than the equivalent Tyr B in the other side of the hexamer.
The ﬁnal structure of the system is as follows: peptides A, B,
and C have parallel β-sheets formed between Ile31−Val36 and
Val39−Val40. Peptides A and B also have a β-sheet between
Glu3−Arg5, which was lost in C. Furthermore, the initial β-
sheets in the mid-section of these peptides have disappeared,
which is why the mid-sections spread apart as discussed above.
Peptides D, E, and F remain structured throughout, with β-
sheets around residues Phe4−Hsd6, Gln15−Phe20, and
Ile31−Val36; it has been seen in other trajectories which
only contained, for example, peptides A−C structured in a
manner similar to those seen in this hexamer. E and F also
contain a β sheet at the tail around Val39−Val40. The lack of
stability might be caused by the low ion count in the system, so
that long-range screening eﬀects are missing. This becomes
more apparent when we compare to the same system
simulated in an ionic solution (EI) as discussed below.
The rotamer states for peptides A, C, E, and F from the EI
simulation are shown in Figure 8. For these ﬁbril structures,
there is a more signiﬁcant shift toward rotamer states 3 and 4
with respect to the amorphous aggregates, as well as the
occupation of states 5 and 6. There are exceptions however;
Tyr D’s environment is more akin to that of a monomer than
an aggregate, and similarly Tyr E’s side-chain moves quite
freely and spends about 25% of its time in states 1 and 2 (see
Figure 8C). These variations are expected because of the
stochastic nature of the simulations.
Figure 5. Six-monomer system aggregating to an amorphous tetramer
and a dimer, at times 0 (A), 20 (B), and 30 ns (C). Peptides A−F are
shown in blue, red, gray, orange, yellow, and tan, respectively. Tyr
residues are shown in green.
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Nevertheless, there does seem to be a more distinct feature
arising in the rotamer statistics. The most notable diﬀerence
between this protoﬁbril and the previous simulations is the
appearance of rotamer states 5 and 6 in peptides A, C, E, and
F. Despite not being seen previously, it is evident that these are
distinct states that can be occupied at diﬀerent points
throughout the trajectory, with ﬁnite probabilities of occurring.
As there is a recurring pattern of the Tyr side-chains moving
between states in an ordered fashion (from 1↔ 2, 2↔ 3, 3↔
4, and so on), it is reasonable to suppose that the sudden
appearance of states 5 and 6 could be enabled by a Tyr side-
chain spending more time in states 3 and 4, causing it to have a
higher probability of transitioning from state 4 into state 5 or 6.
Another likely reason for the appearance of these new states
may be the close proximity of the surrounding residues forcing
the Tyr side-chain to ﬂex and rotate more aggressively,
allowing it to enter otherwise unfavorable states 5 and 6.
Hexamer in Ionic Solution (EI). As can be seen above, the
hexamer structure shown in Figure 7C is similar to that of
Figure 7B. The inclusion of an ionic concentration of 0.25
mol/L (EI) is the only diﬀerence in the simulations;
nevertheless, visual inspection of the trajectory indicates that
long-range screening eﬀects35 might lead to the development
of more stable form of the oligomer. The water-box size is
similar to that used previously (∼92 Å × 95 Å × 90 Å) which
is big enough for the hexamer. This trajectory was also
performed for 200 ns, but as there was no real change in
structure after the ﬁrst 110 ns, we show the structure at this
time in Figure 7C.
The trajectory begins in the same structure as above (Figure
7A). The structure remains relatively unchanged for the ﬁrst 10
ns, but with some minor twisting near the head of the stack
containing peptides A−C. After 40 ns, the overall hexamer
structure remains relatively unchanged, except some noticeable
twisting of the mid-section of both stacks. Nothing of interest
occurs until 70 ns where Tyr A and D appear to gain some
freedom and move around more freely, though the aggregate
itself remains signiﬁcantly more stable throughout the 200 ns
trajectory than all previous aggregates. Throughout the
trajectory, the β-sheet sections holding the peptides together
shift and move, but the aggregate is signiﬁcantly more stable
than seen above. Peptides A and B have β-sheet sections within
the regions of Glu3−Arg5, Gln15−Phe20, Ile31−Gly33, and
Gly38−Ile41. Peptide C has β-sheet sections in similar
positions, however as it is not as tightly aggregated it has
some variation (Gln15−Leu17 rather than Gln15−Phe20).
Peptides D and E have β-sheet regions at Glu3−Arg5, Lys16−
Val18, Ala30−Val36, and Val39−Ile41. Peptide F also has
them in these locations, except at the head (Glu3−Arg5)
which has separated itself from the other two peptides.
The rotamer states for Tyr A, B, C, and F in this trajectory
show an overwhelming preferences toward states 3 and 4, but
do not enter states 5 or 6 at all. Tyr D not only shows a distinct
preference to states 3 and 4 but also temporarily enters states 5
and 6, as shown in Figure 8E. Tyr E (shown in Figure 8F) also
enters states 5 and 6 brieﬂy at the start of the trajectory.
■ ROTAMER STATE SUMMARY
Figure 9 presents the angles obtained for the six rotamers
identiﬁed in the simulations above; further details are given in
Supporting Information Table S1. Rotamer 1 is centered (has
mean coordinates) at (X1;X2) = (71;265) which, according to
the deﬁnition introduced in Figure 1, is equivalent to (g+;g+);
rotamer 2 is centered at (X1;X2) = (72;76) = (g+;g+); rotamer
3 at (X1;X2) = (165;92) = (t;g−); rotamer 4 at (X1;X2) =
(166;270) = (t;g+/g−); rotamer 5 at (X1;X2) = (285;80) =
(g−;g+); and rotamer 6 at (X1;X2) = (285;265) = (g−;g+).
The range of the angular variation for each rotamer depends
on the immediate environment of the Tyr side-chain. Despite
the outliers caused by statistical ﬂuctuations, there is
Figure 6. Tetramer rotamer states. In each panel, the left graph plots the dihedral angle X1 against X2, and the right graph shows how the Tyr
residues move between the rotamer states. (A−D) Peptides A, B, C, and E, respectively.
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consistency in the general areas occupied by the rotamers,
regardless of aggregate type (monomer, amorphous, or proto-
ﬁbrillar). In a recent quantum chemical study, only four Tyr
rotamers (a combination of g+ and g−) were identiﬁed.36 The
discrepancy probably comes from the fact that in quantum
calculations, only single molecules were taken into account and
environmental eﬀects could not be fully included for the Tyr
side-chain.
As the amorphous aggregate becomes more tightly packed,
the Tyr side-chains will interact more closely with surrounding
residues/backbones of other peptides and will have less
exposure to water. This aﬀects the Tyr side-chain movements,
and they begin to more readily ﬂex into positions that are
unfavorable in a monomer.
As is indicated in Table 1, monomers show some occupation
of the ﬁrst 4 rotamer states but with preference to states 1 and
2 as described previously.28 The amorphous aggregates show
approximately equal preference for all states 1−4; however,
this could be misleading; the peptides begin as monomers
before eventually stabilizing as an aggregate, which means that
the occupancy of states 1 and 2 could still be biased by the
initial stages of aggregation, although it is diﬃcult to precisely
distinguish this eﬀect in the simulation data.
■ CONCLUSIONS
The series of simulations reported here show that the rotamer
state occupation of the Tyr side-chains is strongly dependent
on the Tyr side-chain’s immediate environment. Consequently,
amorphous aggregates have a diﬀerent rotamer proﬁle to
monomers, and the protoﬁbril β-sheet structures reveal two
new rotamer states that appear to be uniquely associated with
them. This observation could pave the way to use intrinsic
ﬂuorescence of the Tyr residues to monitor not only the initial,
amorphous stages of Ab aggregation (as done previously28),
but also to detect the onset of ﬁbril formation without using
the extrinsic ﬂuorescence sensors indicating appearance of β-
sheets or ﬁbrillisation (e.g., ThioﬂavinT) that might interfere
with the natural aggregation. Indeed, the existence of six
diﬀerent Tyr rotamers in the heterogenic Ab oligomers may be
conﬁrmed if each rotamer has its distinctive ﬂuorescence
characteristics (e.g., ﬂuorescence lifetime). In this case, the
contributions of the Tyr rotamers in the aggregating Ab could
be determined in ﬂuorescence intensity decay measurements,
providing that the quantum yield of all rotamers is suﬃciently
high to be identiﬁed in the ﬂuorescence signal.
Our results also suggest that excess solution ions may cause
protein conformational changes because of the electrostatic
screening eﬀect. This could aﬀect the stabilization or
conformation of an aggregate and potentially make more
tightly (stable) aggregated systems which may allow for
rotamers 5 and 6 to appear more readily in protoﬁbrils. The
ionicity-induced changes in the Tyr surroundings, together
with the direct ion−Tyr interactions, are likely to modify the
experimentally observed ﬂuorescence responses.
The rotamers 5 and 6 (illustrated in Figure 1C) are a novel
ﬁnding from this work. These states do not appear to be
Figure 7. (A) Initial conﬁguration of a stable protoﬁbril hexamer, with
water shown to indicate the water-box size. (B) β-sheet hexamer
without screening ions (NEI system) depicted at time 200 ns. (C) β-
Figure 7. continued
sheet hexamer in 0.25 mol/L ionic solution (EI system) depicted at
time 110 ns. Peptides A−F are shown in blue, red, gray, orange,
yellow, and tan, respectively. The ions are shown as gray vdW spheres
and the Tyr residues are shown in green.
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artefacts as they are present at various stages of the diﬀerent
protoﬁbril trajectories. However, we note that they do not
occur in the second half of our trajectories, and we believe that
this might be due to the instability of our small protoﬁbril
fragments arising from their short length, a feature that would
be mitigated in larger systems with longer protoﬁbrils; further
work on this point is required. It is also clear from the results
that these states are directly caused by the stacking mechanism,
rather than the mirrored protein within a single layer of a ﬁbril.
The detection of these new rotamers may still be possible
despite their low occupation (see Table 1). This is because
although they only appear occasionally in our quasi-stable
structures, in larger ﬁbrils they will appear more often as there
are more Tyr residues that will also be more tightly packed
together. Experimental work using ﬂuorescence spectroscopy
could potentially be used to help identify these new rotamer
states through lifetime analysis in non-aggregated and
aggregating systems. Detection of these states could provide
better understanding of the aggregation and ﬁbrillation kinetics
and also provide a label-free method to study the inﬂuence of
additives on the aggregation, paving the way to enhanced drug
discovery studies.
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The Supporting Information is available free of charge on the
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ga.8b02408.
We provide full sets of rotamer statistics from the
simulations using three Ab1−42; a set from a Ab1−40
Figure 8. Sample results of protoﬁbril hexamer rotamers with (EI) and without ions (NEI) in solution. In each panel, the left graphs show the
dihedral angle X1 against the dihedral angle X2, and the right graphs show how the Tyr residues move between the rotamer states. (A−C) Peptides
A−C, respectively, in NEI systems, whereas (D−F) show peptides F, D, and E, respectively, in EI systems.
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dimer; the sets from the six Ab1−42 simulation and from
the protoﬁbril simulations for EI and NEI systems; and
we also tabulate the central coordinates of the rotamer
states found in our various Ab1−42 and Ab1−40
simulations (PDF)
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Söldner, R.; Dzubiella, J. Effects of Hofmeister Ions on the α-Helical
Structure of Proteins. Biophys. J. 2012, 102, 907−915.
(34) Hortschansky, P.; Schroeckh, V.; Christopeit, T.;
Zandomeneghi, G.; Fa ̈ndrich, M. The aggregation kinetics of
Alzheimer’s β-amyloid peptide is controlled by stochastic nucleation.
Protein Sci. 2005, 14, 1753−1759.
(35) Gebbie, M. A.; Dobbs, H. A.; Valtiner, M.; Israelachvili, J. N.
Long-Range Electrostatic Screening in Ionic Liquids. Proc. Natl. Acad.
Sci. U.S.A. 2015, 112, 7432−7437.
(36) Yang, B.; Liu, S.; Lin, Z. Computational study on single
molecular spectroscopy of tyrosinglycine, tryptophane-glycine and
glycine-tryptophane. Sci. Rep. 2017, 7, 15869.
ACS Omega Article
DOI: 10.1021/acsomega.8b02408
ACS Omega 2018, 3, 16046−16056
16056
